⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBOT News
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT to Participate in the Jefferies Global Healthcare Conference in London
globenewswire.com
BBOT
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
globenewswire.com
BBOT
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing
globenewswire.com
BBOT
BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
globenewswire.com
BBOT
BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
globenewswire.com
BBOT